Featured snippet from the web
Udenafil is a potent novel phosphodiesterase-5 inhibitor approved for use in Korea. Udenafil has unique properties, with a T max of 1.0–1.5 h and a T 1/2 of 11–13 h (a relatively rapid onset and a long duration of action). Therefore, both on-demand and once-daily use of udenafil have been reported.
People also ask
Choose what you’re giving feedback on
Or give general feedback
The drug udenafil is marketed under the trade name Zydena. It is within the PDE₅ inhibitor class. Like other PDE₅ inhibitors, it is used to treat erectile dysfunction. Udenafil was developed by Dong-A Pharmaceutical. It has fairly rapid onset of action, and has long duration of action. Wikipedia
Molar mass: 516.657 g/mol
ChemSpider ID: 5293720
Elimination half-life: 7.3–12.1 hours
ATC code: G04BE11 (WHO)
Mar 19, 2008 — Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and ...
Udenafil is a novel PDE-5 inhibitor recently studied in 30 patients undergoing Fontan operation [25c]. Udenafil has comparable selectivity for PDE5 as ...
May 14, 2014 — Udenafil is one of the selective PDE5Is made available in recent years for the treatment of ED. Udenafil has clinical properties of both ...
by YS Shim2011Cited by 34 — Udenafil (Zydena), which is the most recently developed PDE5 inhibitor, is also used in some countries, such as Korea, Russia, Ukraine and ...
by MC Cho2014Cited by 29 — Udenafil is one of the selective PDE5Is made available in recent years for the treatment of ED. Udenafil has clinical properties of both ...
May 5, 2017 — Prostate Cancer With Radical Prostatectomy, Drug: ZYDENA TAB.75mg(Udenafil 75mg) Drug: Placebo Oral Tablet, Phase 4 ...
Oct 22, 2013 — The drug being tested in this study is called Udenafil. Udenafil is being tested to treat lower urinary tract symptoms (LUTS) associated with ...
udenafil. A benzenesulfonamide derivative with vasodilatory activity. Udenafil selectively inhibits phosphodiesterase type 5 (PDE5), thus inhibiting the ...